![JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials](https://www.mdpi.com/jcm/jcm-09-01062/article_deploy/html/images/jcm-09-01062-g001.png)
JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials
![PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram](https://www.researchgate.net/publication/339584142/figure/fig1/AS:863741184851968@1582943354413/PIONEER-AF-PCI-Trial-Inclusion-and-Main-Exclusion-Criteria-and-Study-Design_Q640.jpg)
PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram
Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter
![臨床藥學] PIONEER AF-PCI:心房顫動合併冠心症接受心導管治療,Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS 臨床藥學] PIONEER AF-PCI:心房顫動合併冠心症接受心導管治療,Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS](https://4.bp.blogspot.com/-ki6zrPeBWxI/WCpzKF9yAbI/AAAAAAABXc4/evvkGYfo10QidY4RLi4YXaODj2ZOT5-hgCLcB/s1600/NEJS%2B20160905.png)
臨床藥學] PIONEER AF-PCI:心房顫動合併冠心症接受心導管治療,Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS
![Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter](https://pbs.twimg.com/media/D5ORU8FVUAAE_iF.jpg)
Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter
![Can the Dual vs Triple Therapy Controversy in Patients With AF Undergoing PCI Be Put to Rest? - ppt download Can the Dual vs Triple Therapy Controversy in Patients With AF Undergoing PCI Be Put to Rest? - ppt download](https://slideplayer.com/slide/17574620/104/images/7/PIONEER+AF-PCI+Study+Design.jpg)
Can the Dual vs Triple Therapy Controversy in Patients With AF Undergoing PCI Be Put to Rest? - ppt download
PIONEER AF-PCI: Rivaroxaban + P2Y12 Inhibitor clopidogrel ~94% or Rivaroxaban + DAPT vs. Warfarin + DAPT in Patients with Atrial
![Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation | Circulation: Cardiovascular Interventions Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/3fa2a81c-97da-4aaa-b5ee-0701655b90aa/e008160fig03.jpg)
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation | Circulation: Cardiovascular Interventions
![The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/styles/large_slide_teaser/public/2016-11/4441278.png?itok=lIex0IXQ)
The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com
![Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology](https://bjcardio.co.uk/wp-content/uploads/2018/04/PIONEER-2-fig-2.png)
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology
![Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? - ScienceDirect Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352906720302670-gr4.jpg)
Meta-analysis study on direct oral anticoagulants vs warfarin therapy in atrial fibrillation and PCI: Dual or triple approach? - ScienceDirect
![Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI ( PIONEER): Three May End Up Being a Crowd - Samuel A. Berkman, 2018 Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI ( PIONEER): Three May End Up Being a Crowd - Samuel A. Berkman, 2018](https://journals.sagepub.com/cms/10.1177/1076029617710334/asset/images/large/10.1177_1076029617710334-fig2.jpeg)
Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI ( PIONEER): Three May End Up Being a Crowd - Samuel A. Berkman, 2018
![Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology](https://bjcardio.co.uk/wp-content/uploads/2018/04/PIONEER-2-Figure-1.png)
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology
![Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI | Challenges in Cardiology Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI | Challenges in Cardiology](https://challengesincardiology.com/wp-content/uploads/2016/11/Diapositivo7.png)